Kamal Kishore Sharma

Dr. Kamal Kishore Sharma is a Chairman at Viyash Scientific Ltd., a Chairman at Alivira Animal Health Ltd., an Independent Director at Alivira Animal Health Ltd. (Ireland), a Non-Executive Chairman at Shalina Healthcare Ltd. and a Senior Advisor at The Carlyle Group LP.
He is on the Board of Directors at Assetz Buildwell LLP, Faisa Financial Pvt Ltd., Generic Health Pty Ltd., Laboratorios Karizoo SA, Lupin GmbH, Lupin Healthcare Ltd., Pharma Dynamics Pty Ltd., Shalina Healthcare DMCC FZE, Symed Laboratories Ltd., Temple Wellness Ventures LLP, Templecraft Realty LLP, Templeriviere Property LLP, Templetree Properties Pvt Ltd., Viyash Life Sciences Pvt Ltd. and Alivira Animal Health Ltd. (Ireland).
Dr. Sharma was previously employed as an Independent Director by Shilpa Medicare Ltd., a Non-Executive Vice Chairman by Lupin Ltd., a President & Chief Executive Officer by RPG Life Sciences Ltd., a Managing Director by Lupin Chemicals Ltd., and a Member-Management Board by R P G Enterprises Ltd. He also served on the board at Kyowa Pharmaceutical Industry Co., Ltd. He received his undergraduate degree from Indian Institute of Technology Kanpur, an undergraduate degree from Harvard Business School and a doctorate degree from Indian Institute of Technology Bombay.